Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/H5fMcrA3t-o/258418.php
Monday, 1 April 2013
Invokana (canaglifozin) For Type 2 Diabetes Approved By FDA
The FDA has approved Johnson & Johnson's Invokana (canaglifozin) tablets, to be used with exercise and diet, for adults with type 2 diabetes to improve glycemic control. Type 2 diabetes affects approximately 24 million Americans. Patients eventually tend to have complications from high blood sugar levels, including kidney damage, nerve damage, blindness and heart disease. Mary Parks, M.D...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment